BioMarin Pharmaceutical Competitors and Similar CompaniesClear all
BioMarin Pharmaceutical's competitors and similar companies include CSL Behring, Biogen, UCB and Genentech.
 BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ||
Founding Date | Founding Date 1997 | Founding Date 1904 | Founding Date 1978 | Founding Date 1928 | Founding Date 1976 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 3,0015% increase | Employees 7,5692% decrease | Employees 7,605 | Employees 9,052 | Employees 18,077 |
Valuation ($) | Valuation ($) 13.3 b | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $717.4m (FY, 2025) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A |
Net income | Net income $348.9m (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 100 (Dec, 2020) | Countries N/A | Countries 35 (FY, 2019) | Countries N/A |
Patent Applications | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products 28 (Jul, 2025) |
Phase I/II Trials Products | Phase I/II Trials Products 2 (FY, 2016) | Phase I/II Trials Products N/A | Phase I/II Trials Products 1 (FY, 2022) | Phase I/II Trials Products N/A | Phase I/II Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products 19 (Jul, 2025) |
Phase III Trials Products | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products 41 (Jul, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company